🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Sarcoma of Soft Tissue

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy NCT07261657EARLY Phase 11 site📍 Chicago Seth Pollack · Tests: Biospecimen Collection, Computed Tomography, Leukapheresis, Magnetic Resonance Imaging, Nogapendekin Alfa Inbakicept Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago · Tests: Cytalux Development of Clinical and Biological Database NCT03449264NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: biological collection Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma NCT07725380Phase 1, Phase 24 sites📍 Tampa📍 St Louis📍 The Bronx H. Lee Moffitt Cancer Center and Research Institute · Tests: Domatinostat, Sirolimus Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors NCT06926283Phase 14 sites📍 Changsha📍 Hangzhou📍 Beijing Hangzhou DAC Biotechnology Co., Ltd. · Tests: DXC008 A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: REC617 Observational Study in Localized Osteosarcoma NCT04890067n/a16 sites📍 Aviano📍 Candiolo📍 Trieste Italian Sarcoma Group · Tests: Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any… Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma NCT04389281Phase 14 sites📍 Washington D.C.📍 Charlotte📍 Durham Immunolight, LLC · Tests: X-PACT PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial NCT07227571Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: FH FOLR1 ST CAR T-cells, Leukapheresis, Fludarabine, Cyclophosphamide, Echocardiography Test Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis NCT04557969n/a1 site📍 Bethesda National Cancer Institute (NCI) Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas NCT07071727NA6 sites📍 Amsterdam📍 Amsterdam📍 Groningen The Netherlands Cancer Institute · Tests: Preoperative radiotherapy Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST) NCT06222203n/a1 site📍 Bethesda National Cancer Institute (NCI) Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma NCT06327477Phase 1, Phase 21 site📍 Chicago Northwestern University · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Intensity-Modulated Radiation Therapy, Resection A Study of Propranolol to Treat Kaposi Sarcoma NCT05797662Phase 26 sites📍 Buenos Aires📍 Rio de Janeiro📍 Salvador AIDS Malignancy Consortium · Tests: Propranolol Propranolol for the Treatment of Kaposi Sarcoma in Adults NCT06445166Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Propranolol Hydrochloride Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy NCT06599957n/a2 sites📍 Bologna📍 Meldola Istituto Ortopedico Rizzoli MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide An Observational Study of Local Relapse After High Grade Osteosarcoma NCT06017518n/a2 sites📍 Bologna📍 Pisa Istituto Ortopedico Rizzoli Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars NCT06375941n/a19 sites📍 Rozzano📍 Aviano📍 Orbassano Italian Sarcoma Group · Tests: Observational Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors NCT07112989n/a1 site📍 Bologna Istituto Ortopedico Rizzoli Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor NCT05146440Phase 1, Phase 24 sites📍 Zaragoza📍 Barcelona📍 Barcelona Grupo Espanol de Investigacion en Sarcomas · Tests: PM14 Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma NCT04199026NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice, Everolimus, Ganitumab Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma NCT06528769Phase 21 site📍 Columbus Gabriel Tinoco · Tests: all-trans retinoic acid, Cemiplimab, Computed Tomography, Magnetic resonance imaging, Biospecimen Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy